SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-278568
Filing Date
2020-10-27
Accepted
2020-10-27 17:00:51
Documents
3
Period of Report
2020-10-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d71549d8k.htm 8-K 19340
2 EX-3.1 d71549dex31.htm EX-3.1 38324
3 EX-3.2 d71549dex32.htm EX-3.2 65360
  Complete submission text file 0001193125-20-278568.txt   124194
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39634 | Film No.: 201264808
SIC: 2834 Pharmaceutical Preparations